The Health, Development and Anti-Malaria Association (HDAMA) announced that it provided various life-saving medicines, medical equipment,and other health servicessupport to more than 600 health ...

Malaria remains a significant global health challenge, causing over 600,000 deaths annually despite existing prevention and treatment measures. Current vaccines and monoclonal antibodies (mAbs) ...

How training health workers and leveraging data-driven insights are reshaping malaria control efforts in high-burden regions of Mozambique.

ANALYSE. Les risques sanitaires ne viennent pas d’une méconnaissance des maladies, mais d’un défaut de prise en charge dans ...

This finding should have implications for the compound's effect on malaria, because messenger RNA molecules of Plasmodium falciparum, the parasite that causes malaria, tend to have stretches with ...

Guillain-Barré Syndrome is an uncommon, rare neurological condition in which the immune system mistakenly attacks the body's nervous system causing muscle weakness, numbness, and in extreme cases, ...

aiming to reduce the burden of Plasmodium falciparum malaria. Set up with an investment of ₹1,500 crore, the plant is configured to produce 10 different vaccines. The President was welcomed ...

Georgia was endemic to at least three species of the malaria parasite - Plasmodium falciparum, Plasmodium malariae and Plasmodium vivax - before the 20th century.

Current efforts focus on the clinical development of a replicon RNA-based vaccine for the prevention of Plasmodium falciparum infection and on culturing the mosquito stages of the parasite for the ...

Transcriptomics of gene expression in Plasmodium falciparum liver-stage parasites reveals transcriptional regulation, metabolic pathways and antigen expression, facilitating vaccine and drug ...